| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 52,143 | 70,201 | 61,848 | 60,016 | | Cost of Revenue | 16,024 | 16,929 | 18,827 | 19,804 | | | Gross Profit |
-
| 53,272 | 43,021 | 40,212 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 14,658 | 17,040 | 15,370 | 13,022 | | Non Recurring |
-
|
-
|
-
| 1,255 | | Others | (3,962) | 15,319 | 5,122 | 2,739 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 20,913 | 22,529 | 23,196 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 25,423 | 20,913 | 22,529 | 23,196 | | Interest Expense | 12,127 | 12,353 | 12,285 | 13,113 | | Income Before Tax | 13,296 | 8,560 | 10,244 | 10,083 | | Income Tax Expense | 5,186 | 3,398 | 3,935 | 3,604 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 8,110 | 5,162 | 6,309 | 6,479 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 8,110 | 5,162 | 6,309 | 6,479 | | Preferred Stock And Other Adjustments | (951) | (1,903) |
-
|
-
| | | Net Income Applicable To Common Shares | $7,159 | $3,259 | $6,309 | $6,479 |
|
0.02% Nasdaq 
Income Statement
